Phase II Study of S‐1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non‐Small Cell Lung Cancer

LESSONS LEARNED. In terms of efficacy and safety, good results were obtained with S‐1 and paclitaxel (PTX) combination therapy. The findings suggest that S‐1 and PTX combination therapy is a feasible treatment option in patients with previously treated non‐small cell lung cancer. BACKGROUND. Althoug...

Full description

Saved in:
Bibliographic Details
Published in:Oncologist
Main Authors: Chihara, Yusuke, Yoshimura, Akihiro, Date, Koji, Takemura, Yoshizumi, Tamiya, Nobuyo, Kohno, Yoshihito, Imabayashi, Tatsuya, Takeuchi, Mayumi, Kaneko, Yoshiko, Yamada, Tadaaki, Ueda, Mikio, Arimoto, Taichiro, Uchino, Junji, Iwasaki, Yoshinobu, Takayama, Koichi
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Inc. 2019
Subjects:
Clinical Trial Results
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693719/
https://ncbi.nlm.nih.gov/pubmed/31040252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0290
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items